TTY Biopharm Company Limited

TPEX:4105 Stock Report

Market Cap: NT$18.4b

TTY Biopharm Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenure4yrs
Board average tenure8.4yrs

Recent management updates

Recent updates

Here's Why TTY Biopharm (GTSM:4105) Can Manage Its Debt Responsibly

Apr 02
Here's Why TTY Biopharm (GTSM:4105) Can Manage Its Debt Responsibly

Is There An Opportunity With TTY Biopharm Company Limited's (GTSM:4105) 43% Undervaluation?

Mar 15
Is There An Opportunity With TTY Biopharm Company Limited's (GTSM:4105) 43% Undervaluation?

Are Dividend Investors Making A Mistake With TTY Biopharm Company Limited (GTSM:4105)?

Feb 25
Are Dividend Investors Making A Mistake With TTY Biopharm Company Limited (GTSM:4105)?

TTY Biopharm Company Limited (GTSM:4105) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

Feb 07
TTY Biopharm Company Limited (GTSM:4105) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

TTY Biopharm Company Limited (GTSM:4105) Analysts Just Cut Their EPS Forecasts Substantially

Jan 19
TTY Biopharm Company Limited (GTSM:4105) Analysts Just Cut Their EPS Forecasts Substantially

What Type Of Returns Would TTY Biopharm's(GTSM:4105) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

Jan 10
What Type Of Returns Would TTY Biopharm's(GTSM:4105) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

TTY Biopharm (GTSM:4105) Has A Pretty Healthy Balance Sheet

Dec 15
TTY Biopharm (GTSM:4105) Has A Pretty Healthy Balance Sheet

How Does TTY Biopharm Company Limited (GTSM:4105) Fare As A Dividend Stock?

Nov 25
How Does TTY Biopharm Company Limited (GTSM:4105) Fare As A Dividend Stock?

CEO

TTY Biopharm has no CEO, or we have no data on them.

Leadership Team

NamePositionTenureCompensationOwnership
Kuo-Chiang Chang
Chief Financial Officerless than a yearno datano data
Shu-Wen Wang
Accounting Officer9.3yrsno datano data
Shu-Fen Huang
Chief Legal & Compliance Officer2.6yrsno datano data
Wei-Ying Yin
Director of Public Affairs Departmentno datano datano data
Jen-Yang Chang
Chief Human Resource Officer5.5yrsno datano data
Si-Yuan Yang
Senior Vice President15.5yrsno datano data
Allen Chu
Head of Intensive Care Business Unitno datano datano data
Ching-Lan Hou
General Manager2.6yrsno datano data
Yung-Min Chiang
Chief Auditorno datano datano data

4.0yrs

Average Tenure

Experienced Management: 4105's management team is considered experienced (4 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Tze-Kaing Yang
Director8.4yrsno datano data
Chuan-Quan Lin
Chairman of the Board13.4yrsno data0.084%
NT$ 15.5m
Ming-Ling Hsueh
Independent Director8.4yrsno datano data
Wen-Hwa Chang
Vice Chairman29.3yrsno data7.56%
NT$ 1.4b
Ying-Ying Liao
Director8.4yrsno datano data
Carl Hsiao
Representative Director5.7yrsno data0.35%
NT$ 65.1m
Ming-Dao Chang
Independent Directorless than a yearno datano data
An-Li Zheng
Independent Directorless than a yearno datano data
Shi-Chang Xu
Representative Directorless than a yearno datano data

8.4yrs

Average Tenure

69yo

Average Age

Experienced Board: 4105's board of directors are considered experienced (8.4 years average tenure).